MedPath

BLEDINA

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis

Completed
Conditions
Dermatitis, Allergic Contact
Infectious Diseases
First Posted Date
2019-12-02
Last Posted Date
2023-03-13
Lead Sponsor
Bledina
Target Recruit Count
334
Registration Number
NCT04182425
Locations
🇫🇷

Medical Office, Taverny, France

Impact of a Fermented Infant Formula in Weaning Babies

Not Applicable
Completed
Conditions
Weaning
First Posted Date
2009-03-09
Last Posted Date
2009-03-09
Lead Sponsor
Bledina
Target Recruit Count
91
Registration Number
NCT00858026
Locations
🇫🇷

Cabinet médical, Roncq, France

🇫🇷

Cabinet medical, Lambersart, France

🇫🇷

Hôpital saint Vincent de Paul, Lille, France

Prevention of Cow's Milk Allergy in Children

Not Applicable
Completed
Conditions
Milk Hypersensitivity
First Posted Date
2008-11-17
Last Posted Date
2008-11-17
Lead Sponsor
Bledina
Target Recruit Count
142
Registration Number
NCT00792090
Locations
🇫🇷

Hôpital central, Nancy, France

🇫🇷

Hôpital Saint Vincent de Paul, Paris, France

Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency

Not Applicable
Suspended
Conditions
Latent Iron Deficiency
Interventions
Drug: Blédilait Biofer®
Drug: Bledilait Biofer®
First Posted Date
2007-11-07
Last Posted Date
2008-11-17
Lead Sponsor
Bledina
Target Recruit Count
249
Registration Number
NCT00554814
Locations
🇫🇷

Alain BOCQUET, Besançon, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.